Stenorol Crypto

1 x 1 l

Oral solution

Active substance

Halofuginone (Halofuginone lactate) : 0,5 mg/ml

ATC code

QP51AX08 Halofuginone

QP51AX Other antiprotozoal agents

QP51A Agents against protozoal diseases

QP51 Antiprotozoals

QP Antiparasitic products, insecticides and repellents

Species

Cattle (Newborn calves).

Indications

In newborn calves:

• Prevention of diarrhoea due to diagnosed Cryptosporidium parvum, in farms with history of cryptosporidiosis.

Administration should start in the first 24 to 48 hours of age.

• Reduction of diarrhea due to diagnosed Cryptosporidium parvum.

Administration should start within 24 hours after the onset of diarrhoea.

In both cases, the reduction of oocysts excretion has been demonstrated.

Dose to be administered and administration route

For oral use in calves after feeding.

The dosage is: 100 µg of halofuginone/kg bw/ once a day for 7 consecutive days, i.e. 2 ml of the veterinary medicinal product/10 kg bw/ once a day for 7 consecutive days.

To ensure a correct dosage, the use of either a syringe or any appropriate device for oral administration is necessary.

The consecutive treatment should be done at the same time each day.

Once the first calf has been treated, all the forthcoming new-born calves must be systematically treated as long as the risk for diarrhoea due to C. parvum persists.

Adverse reactions

Newborn calves:

Very rare

(< 1 animal / 10,000 animals treated, including isolated reports)

Diarrhoea¹

¹Increase of the level.

Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See the package leaflet for respective contact details.